Journal of Biomedical Materials Research Part A
© Wiley Periodicals, Inc.
Edited By: James M. Anderson
Impact Factor: 3.369
ISI Journal Citation Reports © Ranking: 2014: 13/76 (Engineering Biomedical); 16/33 (Materials Science Biomaterials)
Online ISSN: 1552-4965
Associated Title(s): Journal of Biomedical Materials Research Part B: Applied Biomaterials
Visit the new Author Services today! Features include:
- Free access to your article for 10 of your colleagues; each author of a paper may nominate up to 10 colleagues. This feature is retrospective—even articles already published offer this feature for free colleague access.
- Access in perpetuity to your published article.
- Production tracking for your article and easy communication with the Production Editor via e-mail.
- A list of your favorite journals with quick links to the Editorial Board, Aims & Scope, Author Guidelines and if applicable the Online Submission website; journals in which you have tracked production of an article are automatically added to your Favorites.
- Guidelines on optimizing your article for maximum discoverability.
Aims and Scope
The Journal of Biomedical Materials Research Part A is an international, interdisciplinary, English-language publication of original contributions concerning studies of the preparation, performance, and evaluation of biomaterials; the chemical, physical, toxicological, and mechanical behavior of materials in physiological environments; and the response of blood and tissues to biomaterials. The Journal publishes peer-reviewed articles on all relevant biomaterial topics including the science and technology of alloys,polymers, ceramics, and reprocessed animal and human tissues in surgery,dentistry, artificial organs, and other medical devices. The Journal also publishes articles in interdisciplinary areas such as tissue engineering and controlled release technology where biomaterials play a significant role in the performance of the medical device.
The Journal of Biomedical Materials Research is the official journal of the Society for Biomaterials (USA), the Japanese Society for Biomaterials, the Australasian Society for Biomaterials, and the Korean Society for Biomaterials.
Articles are welcomed from all scientists. Membership in the Society for Biomaterials is not a prerequisite for submission.
Online Submission and Peer Review
In taking a step toward expediting the publication process, Journal of Biomedical Materials Research Part A is pleased to offer web-based submission and peer review.
To submit your manuscript online please:
Log on to http://mc.manuscriptcentral.com/jbmr-a .If you have not already done so, create an account for yourself in the system by clicking on the "Create an Account" button. To monitor the progress of your manuscript throughout the review process, just login periodically and check your Author Center.
Please be sure to study the Instructions and Forms given at the site carefully, and then let the system guide you through the submission process.Online help is available to you at all times during the process. You are also able to exit/re-enter at any stage before finally “submitting” your work. All submissions are kept strictly confidential. If you have any questions, do not hesitate to contact us at firstname.lastname@example.org.
To ensure the most rapid review process for submitted manuscripts, it is now a requirement for authors to suggest at least 4 possible reviewers for their paper with complete contact information, including name,affiliation,and email address. Please note that it is a requirement to include the affiliated institution of each preferred reviewer. We also strongly recommend that you list the reviewer's institutional email address, instead of their personal account. Your submission will be unsubmitted to address these issues if they are not listed correctly.
All correspondence should be sent to the Journal AdministrationOffice, Attn: Ms. Lisa Brodsky, Assistant Managing Editor, Journal of Biomedical Materials Research Editorial Office, c/o John Wiley & Sons, Inc.,111 River Street (MS 8-02), Hoboken, NJ 07030-5774.
Authors in Japan please note: Wiley-Japan can provide authors in Japan with a list of recommended services to check and improve the English in their papers BEFORE SUBMISSION. Please see the site as follows: http://www.blackwellpublishing.com/bauthor/english_language.asp
Copyright/Licensing and Permissions:
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper. For authors signing the copyright transfer agreement:
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp
For authors choosing OnlineOpen: If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:
Creative Commons Attribution License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services
http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
It is the author’s responsibility to obtain written permission to reproduce material that has appeared in another publication.
Use of Animals: When animals are used in the research reported,the authors must state: "NIH guidelines (or for non-U.S. residents similar national regulations) for the care and use of laboratory animals (NIH Publication #85-23 Rev. 1985) have been observed." In studies involving human subjects, the authors must include; "all subjects enrolled in this research have responded to an Informed Consent which has been approved by my Institutional Committee on Human Research and that this protocol has been found acceptable by them." The dates of approval by the Committee and the ethical guidelines followed should be made a part of the Methods section.
Conflict of Interest. JBMR has adopted a policy that requires authors to make a statement concerning potential conflict of interest relating to their submitted articles. They must select one of the following applicable statements as indicated by superscript following the title of their manuscripts.
1. The author, or one or more of the authors, has received or will receive remuneration or other prequisites for personal or professional use from a commercial or industrial agent in direct or indirect relationship to their authorship. 2. The benefits accruing to the author or authors from a commercial or industrial party will be applied to a research fund, nonprofit institution or other organization with which the author(s) are associated. 3. No benefit of any kind will be received either directly or indirectly by the author(s). 4. The author(s) choose not to respond to any of the above listed statements.
Instructions for Manuscript Preparation
Manuscript: For optimal production, prepare manuscript text in size 12 font on 8-1/2 x 11 inch page, double-spaced, with at least 1-inch margins on all sides. Text files should be formatted as .doc or .rtf files. Refrain from complex formatting; the Publisher will style your manuscript according tot the Journal design specifications. Do not use desktop publishing software such as PageMaker or Quark Xpress or other software such as Latex. If you prepared your manuscript with one of these programs, export the text to a word processing format. Please make sure your word processing programs “fast save” feature is turned off. Please do not deliver files that contain hidden text: for example, do not use your word processor’s automated features to create footnotes or reference lists.
Original Articles should appear in the following order: title page (including authors and affiliations), abstract, keywords, introduction, materials and methods, results, discussion, acknowledgments, references, figure legends. Number pages consecutively starting with the title page as page 1.
Please be sure to submit your illustrations and tables as separate files; the system will automatically create a pdf file of your paper for the reviewers.
Title Page: The name(s) and affiliation of the author(s)should appear only on a separate title page. Please do not mark any other parts of the manuscript with name(s) and affiliation(s) of author(s).Use only a short title on the following pages of the manuscript. Author(s) name(s)should not be used. The paper should be subdivided into the expected classical sections and, if necessary, subsections. Manuscripts including references (but not figures or tables) should be no longer than 18 pages.
Abstract: A short synopsis (200 words or less) is required for all papers. This synopsis should be carefully prepared, for it is the source of most abstracts. The synopsis should be a summary of the entire paper, not the conclusions alone, and should precede the main body of the paper.
Keywords: The author is requested to supply, below the synopsis, a list of five keywords or phrases that most clearly typify the outstanding points made in the manuscript.
All references should be numbered consecutively in order of appearanceand should be as complete as possible. Sample references follow:
King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.
Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.
Gilmor ML, Rouse ST, Heilman CJ, Nash NR, Levey AI. Receptor fusion proteins and analysis. In: Ariano MA, editor. Receptor localization. New York: Wiley-Liss; 1998. p 75-90. Please note that journal title abbreviations should conform to the practices of Chemical Abstracts.
Figure Legends: Please supply complete captions for all figures.Captions are to appear on a separate page at the end of the manuscript. Symbols and Equations: Authors are cautioned to type, wherever possible, allmathematical and chemical symbols, equations, and formulas and to identify inthe margin all Greek or unusual symbols the first time they are used(e.g.,k,K, , x, ). Underline all vector quantities with a wavy line. Usefractional exponents to avoid root signs. When mentioning a material, chemicalreagent, instrument or other product, use the generic name only. If furtheridentification (proprietary name, manufacturer's name and address) isrequired, list it as a footnote.
Tables: Please save Tables separately and supply numbers andtitles for all. All table columns should have an explanatory heading. Tablesshould be submitted as doc or rtf files (it is preferred that tables areprepared using Word’s table edit tool).
Illustrations: When preparing digital art, please consider:
Resolution: The minimum requirements for resolution are:
1200 DPI/PPI for black and white images, such as line drawings or graphs.
300 DPI/PPI for picture-only photographs
600 DPI/PPI for photographs containing pictures and lineelements,i.e.,text labels, thin lines, arrows.
These resolutions refer to the output size of the file; if youanticipate that your images will be enlarged or reduced, resolutions should beadjusted accordingly.
For the editorial review process, GIF and JPEG files areacceptable; upon submission of a revision, TIFF or EPS files will be required.For the editorial review process, color images may be submitted in RGBcolor;upon revision, CMYK color will be required. Delivery ofproduction-quality files early in the review process may facilitate smooth andrapid publication once a manuscript has been accepted.
Note that these file formats are not acceptable for printing:JPG,GIF,ONG, PCX, PNG, XBM, Word, and Excel. We recommend creating yourgraphics in Photoshop, Illustrator, or Freehand and importing them into yourpage applications as TIFFs with all fonts included. Do not scan figures asJPEGs and convert to TIFFs. For further guidance on preparing digital figurefiles,authors are encouraged to visit http://cjs.cadmus.com/da/applications.asp.
To ensure that your digital graphics are suitable for print purposes,please go to RapidInspector™ at http://rapidinspector.cadmus.com/zwi/index.jsp .Thisfree, stand-alone software application will help you to inspect and verifyillustrations right on your computer.
A legend must be provided for each illustration and must define allabbreviations used therein. Legends should be placed at the end of themanuscript text file.
Color Illustrations: Color figures are generally printed inthe Journal at the author’s expense. The published will provide cost estimatesprior to printing. A limited number of color figures that are of criticalimportance and that significantly enhance the presentation will be consideredfor publication at the publisher’s expense subject to editorialrecommendation. Final decision on publication of color figures will be at thediscretion of the Editor. All color figures will be reproduced in full colorin the online edition of the journal at no cost to authors. For bestreproduction, bright, clear colors should be used. Dark colors against a darkbackground do not reproduce well; please place your color images againstawhite background wherever possible.
Author Alterations or Revisions. It is absolutely necessary to limit alterations to factual and typographical errors. Authors will be charged for revisions, and publication of their work will be delayed. In order to expedite the publication and online posting of articles in Wiley Online Library,JBMR sends page proofs in pdf format via e-mail to the corresponding author’s e-mail address.Please follow the instructions in the e-mail; contact names and numbers are given for questions, problems, or if an author wishes to receive a paper proof.
Reprints: Reprints may be ordered at https://caesar.sheridan.com/reprints/redir.php?pub=10089&acro=JBMA.
Note to NIH Grantees:
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate.
??? Production Questions ???